Yuexin Yu

Yuexin Yu is a seasoned professional in the investment and biopharmaceutical sectors, currently serving as a Director at Andera Partners since 2021. Yuexin's experience includes roles such as Investment Director at Evommune and Board Member at JenaValve Technology, Inc. Additionally, Yuexin has held positions as a Board Observer with TargED Biopharmaceuticals and a Vice President at 3H Health Investment Management. Early career roles include senior associate and associate positions at Merck, where involvement with projects such as Remicade and Keytruda occurred. Yuexin's educational background includes a Bachelor of Pharmacy from Shanghai Jiao Tong University and advanced studies at HEC Paris and The Wharton School.